Back
SEPT10 Expression in Chronic Lymphocytic Leukemia. Correlation with Clinical and Biological Prognostic Factors
Ana Travella, Julieta Panero, Carmen Stanganelli, Raimundo Bezares, Irma Slavutsky
Open J. Blood Dis. Vol.3 No.3, September 30, 2013  DOI: 10.4236/ojbd.2013.33A003
       (PDF  380K)     HTML     
Polycomb response element-binding sites in the MDR of CLL: Potential tumor suppressor regulation
Christine E. Cutucache, Javeed Iqbal, Philip J. Bierman, Robert Gregory Bociek, Dennis D. Weisenburger, Shantaram S. Joshi
Adv. Biosci. Biotechnol. Vol.4 No.1, January 31, 2013  DOI: 10.4236/abb.2013.41A019
       (PDF  1090K)     HTML     
Clinical Significance of Plasma Levels of Soluble CD40 in Patients with Chronic Lymphocytic Leukemia
Barry D. Hock, Liam J. Fernyhough, Sheryl M. Gough, Judith L. McKenzie
Open J. Blood Dis. Vol.3 No.1, March 28, 2013  DOI: 10.4236/ojbd.2013.31001
       (PDF  261K)     HTML      XML
Correlates of Age at Initial Diagnosis of Chronic Lymphocytic Leukemia: Exercise, ASA & Emotional Distress
Mark W. Ketterer, Emily A. Ketterer, Bernd Barthel, Amr Hanbali, Phillip Kuriakose, Yue Guo, Walter Knysz
Open J. Med. Psychol. Vol.1 No.2, April 16, 2012  DOI: 10.4236/ojmp.2012.12002
       (PDF  69K)     HTML      XML
The Challenges of Diagnosing Disseminated Lyme Disease in a Patient with CLL
Solaiman Futuri, Afshan Malik, Dana Shani
Open J. Blood Dis. Vol.2 No.1, March 01, 2012  DOI: 10.4236/ojbd.2012.21003
       (PDF  50K)     HTML      XML
 
 
Top